(The H4-Index of Helicobacter is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 500 papers]. The publications cover those that have been published in the past four years, i.e., from 2019-12-01 to 2023-12-01.)
The effect of antibiotic resistance on Helicobacter pylori eradication efficacy: A systematic review and meta‐analysis52
PPI‐amoxicillin dual therapy for Helicobacter pylori infection: An update based on a systematic review and meta‐analysis50
Review: Epidemiology of Helicobacter pylori40
Review: Extragastric diseases andHelicobacter pylori38
A comparative study of 14‐day dual therapy (esomeprazole and amoxicillin four times daily) and triple plus bismuth therapy for first‐line Helicobacter pylori infection eradication: A randomized36
A meta‐analysis of the association between Helicobacter pylori infection and risk of atherosclerotic cardiovascular disease34
Review: Pathogenesis of Helicobacter pylori infection34
Changes in the human gut microbiota composition caused by Helicobacter pylori eradication therapy: A systematic review and meta‐analysis31
PCR analysis and specific immunohistochemistry revealing a high prevalence of non‐Helicobacter pylori Helicobacters in Helicobacter pylori‐negative gastric disease patients in Japan: Hig31
The impact of Helicobacter pylori infection, eradication therapy, and probiotics intervention on gastric microbiota in young adults31
Mucoid and coccoid Helicobacter pylori with fast growth and antibiotic resistance29
Review: Diagnosis of Helicobacter pylori infection28
Review – Treatment of Helicobacter pylori infection 202027
Helicobacter pylorifirst‐line and rescue treatments in patients allergic to penicillin: Experience from the European Registry onH pylorimanagement (Hp‐EuReg)26
Time trends and other sources of variation in Helicobacter pylori infection in mainland China: A systematic review and meta‐analysis25
Diagnostic reliability of nested PCR depends on the primer design and threshold abundance ofHelicobacter pyloriin biopsy, stool, and saliva samples24
Helicobacter pylori induced reactive oxygen Species: A new and developing platform for detection24
Helicobacter pylori “Test‐and‐Treat” strategy with urea breath test: A cost‐effective strategy for the management of dyspepsia and the prevention of ulcer and gastric cancer in Spain—Results of24
Effect of probiotics during vonoprazan‐containing triple therapy on gut microbiota in Helicobacter pylori infection: A randomized controlled trial23
Helicobacter pylori eradication treatment and the risk of Barrett's esophagus and esophageal adenocarcinoma23
PPI‐amoxicillin dual therapy four times daily is superior to guidelines recommended regimens in the Helicobacter pylori eradication therapy within Asia: A systematic review and meta‐analysis22
Effects of non‐viableLactobacillus reutericombining with 14‐day standard triple therapy onHelicobacter pylorieradication: A randomized double‐blind placebo‐controlled trial21
Application of a social media platform as a patient reminder in the treatment of Helicobacter pylori21
Gastric microbiota and Helicobacter pylori in Indonesian population21